Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by cartpathcarlon Nov 07, 2018 8:48pm

188 Views

Post# 28941086

RE:RE:Trellis Deal

....and you think Huge is a comparison to NF....C'MON.... they have 3.8 million sg ft of grow space.... on 70+acres....$55million in cash to build a 220,000 sq ft cultivation and extraction facility... at present they are overvalued but they are light years ahead of NF even with Trellis.... (head shake)...

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks